View in EDS

Loss of α-cell GRK2 modulates glucagon response and supports cardiac function.

Saved in:

Bibliographic Details
Title:	Loss of α-cell GRK2 modulates glucagon response and supports cardiac function.
Authors:	Snyder J; Department of Pharmacology and Physiology, Drexel University College of Medicine, Philadelphia, Pennsylvania., Underwood L; Department of Medicine, Division of Cardiovascular Diseases, University of Alabama at Birmingham, Birmingham, Alabama., Jiang CS; Department of Medicine, Division of Cardiovascular Diseases, University of Alabama at Birmingham, Birmingham, Alabama., Kaml V; Department of Medicine, Division of Cardiovascular Diseases, University of Alabama at Birmingham, Birmingham, Alabama., Rajasekaran S; Department of Medicine, Division of Cardiovascular Diseases, University of Alabama at Birmingham, Birmingham, Alabama., Xie L; Department of Medicine, Division of Cardiovascular Diseases, University of Alabama at Birmingham, Birmingham, Alabama., Dotson CR; Department of Medicine, Division of Cardiovascular Diseases, University of Alabama at Birmingham, Birmingham, Alabama., Sato PY; Department of Medicine, Division of Cardiovascular Diseases, University of Alabama at Birmingham, Birmingham, Alabama. Electronic address: psato@uab.edu.
Source:	Molecular pharmacology [Mol Pharmacol] 2026 Apr; Vol. 108 (4), pp. 100115. Date of Electronic Publication: 2026 Mar 04.
Publication Type:	Journal Article
Journal Info:	Publisher: American Society for Pharmacology and Experimental Therapeutics Country of Publication: Netherlands NLM ID: 0035623 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1521-0111 (Electronic) Linking ISSN: 0026895X NLM ISO Abbreviation: Mol Pharmacol Subsets: MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	1521-0111
DOI:	10.1016/j.molpha.2026.100115